P
59.01
1.54 (2.68%)
| 前收盘价格 | 57.47 |
| 收盘价格 | 57.79 |
| 成交量 | 416,149 |
| 平均成交量 (3个月) | 476,922 |
| 市值 | 2,904,128,256 |
| 市盈率 (P/E TTM) | 14.61 |
| 预期市盈率 (P/E Forward) | 12.42 |
| 价格/销量 (P/S) | 2.70 |
| 股市价格/股市净资产 (P/B) | 1.59 |
| 52周波幅 | |
| 利润日期 | 5 Feb 2026 |
| 营业毛利率 | 18.86% |
| 营业利益率 (TTM) | 34.03% |
| 稀释每股收益 (EPS TTM) | 4.29 |
| 季度收入增长率 (YOY) | 7.10% |
| 季度盈利增长率 (YOY) | 1.40% |
| 总债务/股东权益 (D/E MRQ) | 56.91% |
| 流动比率 (MRQ) | 4.20 |
| 营业现金流 (OCF TTM) | 251.52 M |
| 杠杆自由现金流 (LFCF TTM) | 188.69 M |
| 资产报酬率 (ROA TTM) | 6.50% |
| 股东权益报酬率 (ROE TTM) | 12.30% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 看涨 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 看涨 | 混合的 | |
| 股票 | Prestige Consumer Healthcare In | 看跌 | 看跌 |
AIStockmoo 评分
1.7
| 分析师共识 | 1.0 |
| 内部交易活动 | -1.5 |
| 价格波动 | 4.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 1.70 |
|
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Core |
| 内部持股比例 | 1.23% |
| 机构持股比例 | 108.15% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 88.00 (Canaccord Genuity, 49.13%) | 购买 |
| 中 | 72.00 (22.01%) | |
| 低 | 71.00 (Jefferies, 20.32%) | 保留 |
| 平均值 | 77.00 (30.49%) | |
| 总计 | 2 购买, 1 保留 | |
| 平均价格@调整类型 | 61.62 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Canaccord Genuity | 07 Nov 2025 | 88.00 (49.13%) | 购买 | 59.95 |
| Jefferies | 27 Oct 2025 | 71.00 (20.32%) | 保留 | 62.41 |
| Oppenheimer | 21 Oct 2025 | 72.00 (22.01%) | 购买 | 62.49 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| BYOM JOHN E | - | 59.01 | -3,000 | -177,030 |
| 累积净数量 | -3,000 | |||
| 累积净值 ($) | -177,030 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 59.01 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| BYOM JOHN E | 董事 | 25 Nov 2025 | 卖 (-) | 3,000 | 59.01 | 177,030 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合